High-Dividend Passive

Vanguard International High Dividend Yield Index Fund

Vanguard International High Dividend Yield Index Fund (the “Fund”) seeks to track the performance of a benchmark index that measures the investment return of non-U.S. companies that are characterized by high dividend yield.

$48.84

Key Metrics

TER 0.16% per year
Distribution policy Distributing
Fund size USD 21,866 M
Inception date March 2, 2016
Holdings 1,590
Fund currency USD
Fund domicile US
Provider Vanguard
For full official fund details, factsheets, and holdings, visit investor.vanguard.com (opens in new tab).

Compare similar ETFs

Fund Size
Dividend
Fees
Current
International High Dividend Yield Index Fund VIHAX
Fund Size
$21.9B
Dividend
3.6%
Fees
0.16%
Morningstar Total Stock Market Index Fund VTSAX
Fund Size
$2.3T
Dividend
1.0%
Fees
0.04%
Morningstar Total Stock Market Index Fund VITSX
Fund Size
$2.3T
Dividend
1.0%
Fees
0.03%
Morningstar Total Stock Market Index Fund VSMPX
Fund Size
$2.3T
Dividend
1.0%
Fees
0.02%
Morningstar Total Stock Market Index Fund VTI
Fund Size
$2.3T
Dividend
1.0%
Fees
0.03%
View 1342 similar ETFs →

Historical Return

Last updated: Oct 15, 2026
1 Year +0.7% +3.6% Div
3 Years (avg.) +0.2% +3.6% Div
5 Years (avg.) +0.1% +3.6% Div

Risk & Analysis Metrics

Last updated: Oct 15, 2026

Volatility

N/A 1 Year
N/A 3 Years
N/A 5 Years
N/A 10 Years

Max Drawdown

N/A 1 Year
N/A 3 Years
N/A 5 Years
N/A 10 Years

Sharpe Ratio

N/A 1 Year
N/A 3 Years
N/A 5 Years
N/A 10 Years

Distributions

*by ETF Portfolio Weight Last updated: Oct 15, 2026

Profit Margin Distribution

< 0%
1%
1y 3y N/A N/A
0 - 5%
10%
1y 3y N/A N/A
5 - 10%
18%
1y 3y N/A N/A
10 - 15%
15%
1y 3y N/A N/A
15 - 20%
27%
1y 3y N/A N/A
20 - 30%
25%
1y 3y N/A N/A
30 - 40%
3%
1y 3y N/A N/A
> 40%
2%
1y 3y N/A N/A

P/E Ratio Distribution

< 0
1%
1y 3y N/A N/A
0 - 10
16%
1y 3y N/A N/A
10 - 15
37%
1y 3y N/A N/A
15 - 20
21%
1y 3y N/A N/A
20 - 25
19%
1y 3y N/A N/A
25 - 35
5%
1y 3y N/A N/A
35 - 50
0%
1y 3y N/A N/A
> 50
1%
1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap
0.0%
1y 3y N/A N/A
Small Cap
0.0%
1y 3y N/A N/A
Mid Cap
0.3%
1y 3y N/A N/A
Large Cap
40.5%
1y 3y N/A N/A
Mega Cap
59.2%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Portfolio Concentration

*by ETF Portfolio Weight Last updated: Oct 15, 2026
16.5% Top 5 Holdings
28.9% Top 10 Holdings
76.4% Top 50 Holdings
93.8% Top 100 Holdings
Top 5 Companies
HSBC HSBC Holdings Plc
4.0%
RHHVF Roche Holding AG
3.4%
RY Royal Bank Of Canada
3.2%
NVS Novartis AG
3.2%
NSRGY Nestlé SA
2.8%

Latest News

about 1 month ago • benzinga.com

Novartis Myotonic Dystrophy Trial Flop Sends Dyne Therapeutics Shares Tumbling

Dyne Therapeutics Inc. (NASDAQ:DYN) stock is trading lower on Tuesday in reaction to Novartis AG's (NYSE:NVS) data from the global Phase 3 HARBOR s...

about 1 month ago • 247wallst.com

Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%

A failed cholesterol trial from Novartis (NYSE:NVS | NVS Price Prediction) is dragging the Lp(a) drug class lower and hitting Amgen (NASDAQ:AMGN) h...

about 1 month ago • reuters.com

Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers

Shares of Dyne Therapeutics and Sarepta slumped on Tuesday after Novartis' treatment for a muscle-wasting disorder failed in a trial, fueling inves...

Sectors

Finance and Insurance 17.3%
Manufacturing 6.1%
Mining, Quarrying, and Oil and Gas Extraction 5.3%
Health Technology 3.7%
Finance 3.6%
Consumer Non-Durables 3.0%
Information 1.6%
Transportation and Warehousing 1.4%
Utilities 1.3%
Energy 0.9%
Financial Services 0.7%
Professional, Scientific, and Technical Services 0.6%
Electronic Technology 0.5%
Retail Trade 0.3%
Energy Minerals 0.3%
Producer Manufacturing 0.2%
Accommodation and Food Services 0.2%
Wholesale Trade 0.2%
Communications 0.2%
Management of Companies and Enterprises 0.1%
Consumer Durables 0.1%
Real Estate and Rental and Leasing 0.1%
Health Care and Social Assistance 0.1%
Process Industries 0.0%
Real Estate 0.0%
Administrative and Support and Waste Management and Remediation Services 0.0%
Other 52.2%

Countries

Japan 12.0%
United Kingdom 10.3%
Canada 8.5%
Switzerland 7.7%
Australia 7.2%
Taiwan (Province of China) 5.2%
France 5.2%
China 5.2%
Germany 4.4%
Spain 4.4%
Italy 3.3%
Hong Kong 2.1%
Brazil 1.9%
Singapore 1.8%
Korea (the Republic of) 1.7%
Netherlands 1.5%
Sweden 1.4%
Saudi Arabia 1.3%
Other 1.3%
India 1.2%
Denmark 1.1%
South Africa 1.1%
Mexico 1.0%
Finland 1.0%
Israel 0.8%
United States 0.7%
Norway 0.7%
United Arab Emirates 0.7%
Malaysia 0.6%
Thailand 0.6%
Austria 0.5%
Poland 0.5%
Belgium 0.3%
Greece 0.3%
Qatar 0.3%
Indonesia 0.3%
Ireland 0.3%
Hungary 0.3%
Turkey 0.2%
Portugal 0.2%
Chile 0.2%
Kuwait 0.2%
Colombia 0.1%
Philippines 0.1%
Bermuda 0.1%
New Zealand 0.1%
Czechia 0.1%
Cayman Islands 0.1%
Romania 0.1%
Luxembourg 0.1%
Egypt 0.0%
Macao 0.0%
Cyprus 0.0%
Isle of Man 0.0%
Iceland 0.0%
Russian Federation 0.0%
Other 0.0%

Stock Screener

Select filters to narrow down the 186 investments below

186 companies

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap $2.49T
P/E Ratio 13.1
Dividends 4.0%
Total Investment $417.28M
Weight 1.91%

Loading details…

Market Cap $352.94B
P/E Ratio 23.3
Dividends 2.7%
Total Investment $350.85M
Weight 1.60%

Loading details…

Market Cap $380.49B
P/E Ratio 17.2
Dividends 2.4%
Total Investment $333.93M
Weight 1.53%

Loading details…

Market Cap $273.23B
P/E Ratio 21.8
Dividends 3.1%
Total Investment $333M
Weight 1.52%

Loading details…

Market Cap $237.26B
P/E Ratio 26.3
Dividends 4.1%
Total Investment $294.16M
Weight 1.35%

Loading details…

Loading details…

Loading details…

Loading details…

Loading details…

Loading details…

Market Cap $776.33B
P/E Ratio 10.8
Dividends 2.0%
Total Investment $235.08M
Weight 1.08%

Loading details…

Market Cap $34.46T
P/E Ratio 8.3
Dividends 3.4%
Total Investment $232.19M
Weight 1.06%

Loading details…

Market Cap $299.2B
P/E Ratio 17.5
Dividends 2.7%
Total Investment $228.6M
Weight 1.05%

Loading details…

Market Cap $191.77B
P/E Ratio 10.9
Dividends 4.4%
Total Investment $194.26M
Weight 0.89%

Loading details…

Market Cap $157.76B
P/E Ratio 16.1
Dividends 2.1%
Total Investment $188.99M
Weight 0.86%

Loading details…

Loading details…

Loading details…

Market Cap $1.13T
P/E Ratio 9.7
Dividends 4.6%
Total Investment $172.2M
Weight 0.79%

Loading details…

Market Cap $492.75B
P/E Ratio 10.8
Dividends 4.1%
Total Investment $162.9M
Weight 0.75%

Loading details…

Market Cap $145.02B
P/E Ratio 21.5
Dividends 3.5%
Total Investment $153.55M
Weight 0.70%

Loading details…